Dysfunctional β-cell autophagy induces β-cell stress and enhances islet immunogenicity
dc.contributor.author | Austin, Matthew C. | |
dc.contributor.author | Muralidharan, Charanya | |
dc.contributor.author | Roy, Saptarshi | |
dc.contributor.author | Crowder, Justin J. | |
dc.contributor.author | Piganelli, Jon D. | |
dc.contributor.author | Linnemann, Amelia K. | |
dc.contributor.department | Biochemistry and Molecular Biology, School of Medicine | |
dc.date.accessioned | 2025-03-24T12:42:59Z | |
dc.date.available | 2025-03-24T12:42:59Z | |
dc.date.issued | 2025-01-29 | |
dc.description.abstract | Background: Type 1 Diabetes (T1D) is caused by a combination of genetic and environmental factors that trigger autoimmune-mediated destruction of pancreatic β-cells. Defects in β-cell stress response pathways such as autophagy may play an important role in activating and/or exacerbating the immune response in disease development. Previously, we discovered that β-cell autophagy is impaired prior to the onset of T1D, implicating this pathway in T1D pathogenesis. Aims: To assess the role of autophagy in β-cell health and survival, and whether defects in autophagy render islets more immunogenic. Methods: We knocked out the critical autophagy enzyme, ATG7, in the β-cells of mice (ATG7Δβ-cell) then monitored blood glucose, performed glucose tolerance tests, and evaluated bulk islet mRNA and protein. We also assessed MHC-I expression and presence of CD45+ immune cells in ATG7Δβ-cell islets and evaluated how impaired autophagy affects EndoC-βH1 HLA-I expression under basal and IFNα stimulated conditions. Lastly, we co-cultured ATG7Δβ-cell islet cells with diabetogenic BDC2.5 helper T cells and evaluated T cell activation. Results: We found that all ATG7Δβ-cell mice developed diabetes between 11-15 weeks of age. Gene ontology analysis revealed a significant upregulation of pathways involved in inflammatory processes, response to ER stress, and the ER-associated degradation pathway. Interestingly, we also observed upregulation of proteins involved in MHC-I presentation, suggesting that defective β-cell autophagy may alter the immunopeptidome, or antigen repertoire, and enhance β-cell immune visibility. In support of this hypothesis, we observed increased MHC-I expression and CD45+ immune cells in ATG7Δβ-cell islets. We also demonstrate that HLA-I is upregulated in EndoC β-cells when autophagic degradation is inhibited. This effect was observed under both basal and IFNα stimulated conditions. Conversely, a stimulator of lysosome acidification/function, C381, decreased HLA-I expression. Lastly, we showed that in the presence of islet cells with defective autophagy, there is enhanced BDC2.5 T cell activation. Conclusions: Our findings demonstrate that β-cell autophagy is critical to cell survival/function. Defective β-cell autophagy induces ER stress, alters pathways of antigen production, and enhances MHC-I/HLA-I presentation to surveilling immune cells. Overall, our results suggest that defects in autophagy make β-cells more susceptible to immune attack and destruction. | |
dc.eprint.version | Final published version | |
dc.identifier.citation | Austin MC, Muralidharan C, Roy S, Crowder JJ, Piganelli JD, Linnemann AK. Dysfunctional β-cell autophagy induces β-cell stress and enhances islet immunogenicity. Front Immunol. 2025;16:1504583. Published 2025 Jan 29. doi:10.3389/fimmu.2025.1504583 | |
dc.identifier.uri | https://hdl.handle.net/1805/46506 | |
dc.language.iso | en_US | |
dc.publisher | Frontiers Media | |
dc.relation.isversionof | 10.3389/fimmu.2025.1504583 | |
dc.relation.journal | Frontiers in Immunology | |
dc.rights | Attribution 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | PMC | |
dc.subject | Type 1 diabetes | |
dc.subject | Autophagy | |
dc.subject | β-cell stress | |
dc.subject | Islet immunogenicity | |
dc.subject | HLA-I expression | |
dc.title | Dysfunctional β-cell autophagy induces β-cell stress and enhances islet immunogenicity | |
dc.type | Article |